cMET Exon 14 Skipping: From the Structure to the Clinic
Keywords: درمان های هدفمند; NSCLC; cMET; Exon 14 skipping; Targeted therapies;
مقالات ISI درمان های هدفمند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Traitements médicaux des cholangiocarcinomes en 2015
Keywords: درمان های هدفمند; Antiangiogéniques; Anti-EGFR; Cancer des voies biliaires; Chimiothérapie; Cholangiocarcinome; Thérapies ciblées; Antiangiogenics; Anti-EGFR; Biliary tract carcinoma; Chemotherapy; Cholangiocarcinoma; Targeted therapies;
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy
Keywords: درمان های هدفمند; Biomarkers; Inflammatory breast cancer; Resistance to chemotherapy; Signaling pathways; Targeted therapies;
Lessons Learned: HIV Points the Way Towards Precision Treatment of Mixed-Lineage Leukemia
Keywords: درمان های هدفمند; LEDGF/p75; integration; MLL; HIV; protein–protein interaction; targeted therapies
Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies
Keywords: درمان های هدفمند; NSCLC; Brain metastases; Radiotherapy; Targeted therapies; EGFR; Anaplastic lymphoma kinase;
Renal carcinoma pharmacogenomics and predictors of response: Steps toward treatment individualization
Keywords: درمان های هدفمند; Kidney cancer; Clear cell renal carcinoma; Targeted therapies; Predictive biomarkers; Antiangiogenics; mTOR inhibitors
Place des traitements innovants du mélanome métastatique chez le sujet âgé
Keywords: درمان های هدفمند; Mélanome; Thérapies ciblées; Immunothérapie; Oncogériatrie; Essais thérapeutiques; Melanoma; Targeted therapies; Immunotherapy; Oncogeriatrics; Clinical trials;
Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia
Keywords: درمان های هدفمند; Chronic myelogenous leukemia; Acute myeloid leukemia; ILK inhibitor; Compound 22; Targeted therapies;
Targeted therapies for advanced Ewing sarcoma family of tumors
Keywords: درمان های هدفمند; Ewing sarcoma; Targeted therapies
High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA)
Keywords: درمان های هدفمند; Lung cancer; Targeted therapies; Alternative splicing; Correspondence analysis; Multivariate statistics;
ReviewMultidisciplinary Management of Locally Advanced Rectal Cancer-An Evolving Landscape?
Keywords: درمان های هدفمند; Adjuvant therapy; Neoadjuvant therapy; Radiotherapy; Surgery; Targeted therapies;
Cancer bronchique non à petites cellules localement avancé : quand et comment intégrer chimiothérapie et radiothérapie ?
Keywords: درمان های هدفمند; Cancer bronchique non à petites cellules; Stade III; Radiothérapie; Chimiothérapie; Thérapeutiques ciblées; Non-small cell lung cancer; Stage III; Chemotherapy; Radiotherapy; Targeted therapies;
Small molecule compounds targeting miRNAs for cancer therapy
Keywords: درمان های هدفمند; MicroRNAs; Small molecules; Targeted therapies; Non-coding RNAs; Cancer
Altérations moléculaires au cours de la carcinogenèse urothéliale vésicale
Keywords: درمان های هدفمند; Tumeur de vessie; Carcinogenèse; Marqueurs moléculaires; Thérapies ciblées; Bladder cancer; Carcinogenesis; Molecular markers; Targeted therapies;
What you are missing could matter: a rare, complex BRAF mutation affecting codons 599, 600, and 601 uncovered by next generation sequencing
Keywords: درمان های هدفمند; Personalized medicine; next generation sequencing; targeted therapies; BRAF mutation
Place de la chirurgie dans la prise en charge des métastases pancréatiques des cancers du rein
Keywords: درمان های هدفمند; Cancer du rein; Métastases pancréatiques; Chirurgie; Thérapies cibléesRenal cell cancer; Pancreatic metastases; Surgery; Targeted therapies
Nouveautés sur les thérapies ciblées dans le cancer du sein
Keywords: درمان های هدفمند; Cancer du sein; Thérapies ciblées; SurvieBreast cancer; Targeted therapies; Survival
B7-H4 as a potential target for immunotherapy for gynecologic cancers: A closer look
Keywords: درمان های هدفمند; Ovarian cancer; B7-H4; Targeted therapies
Valeur pronostique de la toxicité induite par les thérapies ciblées dans le carcinome rénal métastatique
Keywords: درمان های هدفمند; Facteurs pronostiques; Survie; Cancer du rein métastatique; Thérapies ciblées; Toxicité induite; Métastase cérébrale; Prognostic factors; Survival; Metastatic renal cell carcinoma; Targeted therapies; Induced toxicity; Brain metastasis;
Toxicité endobuccale des thérapies ciblées anticancéreuses
Keywords: درمان های هدفمند; Lésions buccales; Thérapies ciblées; Mucite; Ulcérations aphtoïdes; Hyperkératose; Glossite migratrice bénigne; Ostéonécrose de la mâchoire; Oral lesions; Targeted therapies; Mucositis; Aphthous-like lesions; Hyperkeratosis; Benign migratory glo
Prise en charge thérapeutique des patients atteints d'un mélanome cutané métastatique : recommandations nationales françaises
Keywords: درمان های هدفمند; Recommandations pour la pratique clinique; Mélanome cutané métastatique; Traitement; Thérapies ciblées; Chimiothérapie; Clinical practice guidelines; Metastatic cutaneous melanoma; Treatment; Targeted therapies; Chemotherapy;
ReviewMet as a therapeutic target in HCC: Facts and hopes
Keywords: درمان های هدفمند; HGF; MET; Hepatocellular carcinoma; Targeted therapies; Clinical trials;
Integration of genomic information in the clinical management of HCC
Keywords: درمان های هدفمند; Hepatocellular carcinoma; Molecular profiling; Targeted therapies; Biomarker; Gene signatures
A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Keywords: درمان های هدفمند; Angiogenesis; Angiopoietins; Targeted therapies; Tie2 receptor; Vascular growth factor receptor;
Targeting the MET gene for the treatment of non-small-cell lung cancer
Keywords: درمان های هدفمند; Hepatocyte growth factor; MET; Kinase inhibitors; Targeted therapies; NSCLCRTKs, tyrosine kinase receptors; NSCLC, non small cell lung cancer; EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma kinase; MET, hepatocyte growth factor receptor;
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Keywords: درمان های هدفمند; cutaneous T-cell lymphoma; immunomodulators; mycosis fungoides; phototherapy; prognosis; Sézary syndrome; skin-directed treatment; staging; systemic treatment; targeted therapies; topical corticosteroids; topical nitrogen mustard; topical retinoids/rexi
Prognostic factors of brain metastases from breast cancer: Impact of targeted therapies
Keywords: درمان های هدفمند; Breast cancer; Brain metastases; Prognostic factors; HER2; Targeted therapies;
Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research
Keywords: درمان های هدفمند; Adaptive randomization; Biomarker classifiers; Generalized likelihood ratio statistics; Group sequential design; Multiple testing; Targeted therapies;
Surrogate End Points and Postprogression Survival in Renal Cell Carcinoma: An Analysis of First-Line Trials With Targeted Therapies
Keywords: درمان های هدفمند; Overall survival; Phase III trials; Postprogression survival; Progression-free survival; Renal cell carcinoma; Surrogate end points; Targeted therapies
Targeted therapy-induced radiation recall
Keywords: درمان های هدفمند; Radiation recall; Targeted therapies; Radiotherapy; Phase I trial
Improvement in survival of metastatic colorectal cancer: Are the benefits of clinical trials reproduced in population-based studies?
Keywords: درمان های هدفمند; Chemotherapy; Colorectal cancer; Elderly; Population-based study; Survival; Targeted therapies
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options
Keywords: درمان های هدفمند; CLL; Microenvironment; Survival signals; Targeted therapies
Impact des toxicités cutanées associées aux thérapies ciblées sur la qualité de vie. Résultats d'une étude pilote longitudinale
Keywords: درمان های هدفمند; cancer; thérapies ciblées; toxicités cutanées; qualité de vie; cancer; targeted therapies; skin toxicities; quality of life;
Von Hippel–Lindau: How a rare disease illuminates cancer biology
Keywords: درمان های هدفمند; Von Hippel–Lindau; Angiogenesis; HIF; Renal cell carcinoma; Targeted therapies
State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature review
Keywords: درمان های هدفمند; Cardiotoxicity; Anticancer therapy; Cardiovascular toxicity; Targeted therapies; Chemotherapy
Advanced HER2-positive gastric cancer: Current and future targeted therapies
Keywords: درمان های هدفمند; Gastric cancer; Human epidermal growth factor receptor; Trastuzumab resistance; Multitargeted tyrosine kinase inhibitors; Second line therapies; Targeted therapies
Biology of brain metastases and novel targeted therapies: Time to translate the research
Keywords: درمان های هدفمند; Brain metastases; Targeted therapies; Angiogenesis; Radiotherapy; Blood–brain barrier
Nodules pulmonaires excavés chez une femme de 40 ans non fumeuse : une tumeur très particulière
Keywords: درمان های هدفمند; Poumon; Adénocarcinome; Réarrangement EML4-ALK; Thérapeutique ciblée; Kystes pulmonaires; Nodules pulmonaires; Lung adenocarcinoma; EML4-ALK fusion gene; Targeted therapies; Pulmonary cysts; Pulmonary nodules;
Current concepts and significance of estrogen receptor β in prostate cancer
Keywords: درمان های هدفمند; Estrogen receptor beta; Prostate cancer; Phytoestrogens; Prostate cancer prevention; Targeted therapies
Thérapie (multi)ciblées pour le cancer de la thyroïde : qui, quand, comment, pourquoi ?
Keywords: درمان های هدفمند; Cancer de la thyroïde; Réfractaire; Thérapie ciblée; Thyroid cancer; Refractory; Targeted therapies;
Les biomarqueurs à rechercher en 2012 et dans le futur proche dans les cancers bronchiques non à petites cellules (CBNPC)
Keywords: درمان های هدفمند; Cancer bronchiques non à petites cellules (CBNPC); Thérapeutiques ciblées; Biomarqueurs; EGFR; ALK; AMM conditionnée; Non Small Cell Lung Cancer (NSCLC); Targeted therapies; Biomarkers; EGFR; Molecularconditoned registration;
Uveal melanoma
Keywords: درمان های هدفمند; Uveal melanoma; Proton beam irradiation; Enucleation; Targeted therapies; Ipilimumab
Manifestations cutanées des thérapies ciblées
Keywords: درمان های هدفمند; Thérapies ciblées; Effets indésirables cutanés; Ãruption psoriasiforme; Ãruption acnéiforme; Paronychie; Syndrome mains-pieds; Targeted therapies; Cutaneous adverse events; Psoriasiform eruption; Papulopustular eruption; Paronychia; Hand-foot skin
Management of lung cancer
Keywords: درمان های هدفمند; chemotherapy; non-small cell lung cancer; radiotherapy; small cell lung cancer; surgery; targeted therapies;
Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma?
Keywords: درمان های هدفمند; renal; cancer; brain; metastasis; anti-angiogenic; targeted therapies;
Treatment of elderly patients with glioblastoma: From clinical evidence to molecular highlights
Keywords: درمان های هدفمند; Glioblastoma; Elderly patients; Surgery; Radiotherapy; Temozolomide; Targeted therapies
Gestion des thérapies ciblées chez les patients hémodialysés
Keywords: درمان های هدفمند; chimiothérapie; thérapies ciblées; hémodialyse; pharmacocinétique; recommandations d'adaptation posologique; cytotoxic drugs; targeted therapies; hemodialysis; pharmacokinetics; dosing recommendations;
Understanding resistance to targeted cancer drugs through loss of function genetic screens
Keywords: درمان های هدفمند; Targeted therapies; Acquired drug resistance; RNA interference; Loss-of-function genetic screens; Predictive markers
Targeted Therapies for Metastatic Melanoma
Keywords: درمان های هدفمند; Metastatic melanoma; Targeted therapies; Immunotherapy; Signaling pathways;
Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation
Keywords: درمان های هدفمند; HNSCC; Targeted therapies; EGFR; PIK3CA; TP53; P16; TGF-beta; NF-κB; Notch1; HPV;